The global cell lysis market is projected to experience significant growth in the coming years, reaching an estimated USD 4.1 billion by 2026. This marks an increase from USD 2.9 billion in 2021, reflecting a compound annual growth rate (CAGR) of 7.2%. The expansion of the market is driven by various factors such as increased government funding for research, a high prevalence of diseases, and a growing focus on personalized medicine.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321
Key Market Segments
The cell lysis market is segmented based on product, cell type, application, and end user.
Product
Based on product, the market is divided into consumables and instruments. In 2020, consumables held a larger share of the cell lysis market. This can be attributed to the repeated purchase and high consumption of consumables such as enzymes and detergents. The segment’s growth is also supported by the high prevalence of diseases and increased funding for cell-based research.
Cell Type
By cell type, the market is segmented into mammalian, microbial, and other cells. The mammalian cells segment accounted for the largest market share in 2020, driven by rising investments in research activities to develop new treatments for diseases and industrial applications.
Application
The primary application for cell lysis in the market is protein purification, which plays a crucial role in various research and development processes. This application supports drug discovery and development and advances in the biopharmaceutical and biotechnology industries.
End User
Based on end user, the market is categorized into research laboratories and institutes, biopharmaceutical and biotechnology companies, and other end users. In 2020, research laboratories and institutes held the largest market share due to increasing government funding for cell-based research.
Regional Analysis
The cell lysis market is segmented into four major regions: North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest share of the global cell lysis market. This region’s growth is fueled by factors such as increasing stem cell and cancer research activities, expanding biotechnology and pharmaceutical industries, and supportive government initiatives.
Key Market Players
Major players in the cell lysis market include Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), Bio-Rad Laboratories (US), Cell Signaling Technology Inc. (US), Miltenyi Biotec (Germany), Roche Diagnostics (Switzerland), and QIAGEN N.V. (Netherlands). These industry leaders contribute to market expansion through innovative product development, strategic partnerships, and geographic expansion.
Future Outlook
The global cell lysis market is poised for continued growth due to technological advancements in consumables and instruments, as well as increasing investments in research and development. The market will also benefit from rising demand for personalized medicine and targeted therapies.
As researchers and scientists continue to explore cell-based research, the demand for cell lysis products and services will likely rise. This trend, coupled with advancements in biopharmaceuticals and biotechnology, will drive the market’s expansion over the forecast period.
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=260138321
In conclusion, the global cell lysis market is set for robust growth as it plays a critical role in research, diagnostics, and drug development. The industry’s future looks promising as it continues to innovate and adapt to meet the changing needs of researchers and healthcare providers worldwide.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
